PETS Stock Analysis: Buy, Sell, or Hold?
PETS - PetMed Express, Inc.
$3.19
-0.04 (-1.24%)
▼
BUY
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Feb 09, 2026
7d
Get Alerted When PETS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: PETS shows positive signals but monitor for confirmation. Market pricing in 1.6% decline. Moderate conviction.
💡 BUY OPPORTUNITY: PETS shows positive signals but monitor for confirmation. Market pricing in 1.6% decline. Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: PETS is currently trading at $3.19, which is considered oversold relative to its 30-day fair value range of $3.25 to $3.46. The stock's valuation (Forward PE: 319.0) is in line with its historical norms (335.0). Remarkably, the market is currently pricing in an annual earnings decline of 1.6% over the next few years. This pessimistic expectation contrasts with the company's recent 266.7% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, PETS is in a uptrend. The price is currently testing key support at $3.14. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. However, the stock is trading significantly above the average Wall Street target of $2.75. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, PETS is in a uptrend. The price is currently testing key support at $3.14. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. However, the stock is trading significantly above the average Wall Street target of $2.75. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$3.25 -
$3.46
Company Quality Score
64/100
(BUY)
Options IV Signal
50th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
70.0%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Options fairly priced (IV 50th percentile)
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Trading 13.8% above Wall St target ($2.75)
Fair Price Analysis
30-Day Fair Range
$3.25 -
$3.46
Current vs Fair Value
OVERSOLD
Expected Move (7 Days)
±$0.47
(14.6%)
Support & Resistance Levels
Support Level
$3.14
Resistance Level
$3.52
Current Trend
Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
319.00
Wall Street Target
$2.75
(-13.8%)
Revenue Growth (YoY)
-23.6%
Earnings Growth (YoY)
266.7%
Profit Margin
-27.8%
Valuation Discount vs History
-1.6% cheaper
PE vs Historical
319.0 vs 335.0
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-1.6%
(market-implied from PE analysis)
1-Year Target
$3.14
(-2%)
2-Year Target
$3.09
(-3%)
3-Year Target
$3.04
(-5%)
3-Yr Target (if PE normalizes)
(PE: 319→335)
$3.19
(+0%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 319.0 to 335.0
Stabilization Target:
$3.35
(+5.0%)
PE Expansion Potential:
+5.0%
Last updated: February 01, 2026 2:40 AM ET
Data refreshes hourly during market hours. Next update: 3:40 AM
Data refreshes hourly during market hours. Next update: 3:40 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PETS showing a specific setup today?
Insider Activity (6 Months)
1
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Silvercape Investments L…
BUY
101000 shares
2025-08-13
Top Rated Pharmaceutical Retailers Stocks
Top-rated stocks in Pharmaceutical Retailers by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
HITI
High Tide Inc |
STRONG BUY
5 analysts |
$6 | 49 HOLD |
Advanced PETS Option Strategies
Professional options setups generated by AI based on today's PETS price and gamma walls.
